Crestchem Ltd Stock Falls to 52-Week Low of Rs.92.05 Amidst Prolonged Downtrend

Recent Price Movement and Market Context

On 20 Jan 2026, Crestchem Ltd’s share price fell by 2.72%, closing at Rs.92.05, the lowest level seen in the past year. This decline comes after a continuous 10-day losing streak, during which the stock has shed approximately 16.67% of its value. The stock’s performance today also lagged behind the Specialty Chemicals sector by 0.46%, signalling relative weakness within its industry group.

The broader market environment has been challenging as well. The Sensex opened flat but ended the day down by 217.49 points, or 0.31%, closing at 82,989.89. Despite this, the Sensex remains within 3.82% of its 52-week high of 86,159.02. However, the index has been on a three-week losing streak, declining 3.23% over that period, with its 50-day moving average trading below the 200-day moving average, indicating some near-term market pressure.

Technical Indicators Signal Weakness

Crestchem’s technical indicators paint a cautious picture. The stock is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — which typically suggests a bearish trend. This persistent weakness in price action highlights the challenges the company faces in regaining investor confidence and momentum.

Long-Term Performance and Financial Metrics

Over the past year, Crestchem Ltd has delivered a total return of -66.05%, a stark contrast to the Sensex’s positive 7.66% return over the same period. This underperformance extends beyond the last 12 months, with the stock also lagging the BSE500 index over the last three years, one year, and three months.

The stock’s 52-week high was Rs.329, underscoring the magnitude of the decline to its current level. This significant drop reflects underlying concerns about the company’s financial strength and growth prospects.

Fundamental Analysis Highlights

Crestchem’s long-term fundamental strength is considered weak, despite a compound annual growth rate (CAGR) of 19.73% in operating profits over the last five years. The company’s ability to service its debt remains limited, with an average EBIT to interest ratio of 1.75, indicating tight coverage of interest expenses.

Recent financial results have been subdued, with flat performance reported in the half-year ended September 2025. The return on capital employed (ROCE) for the half-year stood at a low 32.96%, signalling limited efficiency in generating returns from capital invested.

Valuation and Profitability Considerations

Despite the challenges, Crestchem maintains a relatively attractive valuation. The stock trades at a price-to-book value of 3.5, supported by a return on equity (ROE) of 25%, which is considered very attractive within its sector. This valuation is broadly in line with historical averages for its peer group, suggesting the market is pricing in the company’s current performance realities.

However, profitability has declined notably, with profits falling by 36.3% over the past year. This contraction in earnings has contributed to the stock’s downward trajectory and reflects pressures on the company’s business model and market conditions.

Shareholding Pattern and Market Position

The majority of Crestchem’s shares are held by non-institutional investors, which may influence liquidity and trading dynamics. The company operates within the Specialty Chemicals industry, a sector that has experienced mixed performance amid broader market fluctuations.

Summary of Key Metrics

Crestchem Ltd’s current Mojo Score stands at 31.0, with a Mojo Grade of Sell, reflecting a downgrade from a previous Strong Sell rating on 16 Jan 2026. The company’s market capitalisation grade is 4, indicating a micro-cap status within the market.

The stock’s recent performance and financial indicators highlight a period of sustained pressure, with multiple factors contributing to its decline to the 52-week low of Rs.92.05. These include subdued profit growth, limited debt servicing capacity, and technical weakness across all major moving averages.

While the stock’s valuation metrics suggest some relative attractiveness, the overall picture remains one of caution given the recent trends and comparative underperformance against benchmarks.

Market and Sector Comparison

Within the Specialty Chemicals sector, Crestchem’s underperformance is notable. The sector itself has experienced mixed results, but Crestchem’s returns have lagged behind both sector averages and broader market indices. The Sensex’s proximity to its 52-week high contrasts with Crestchem’s slide to its lowest price point in a year, underscoring the divergence in performance.

Investors and market participants will continue to monitor the stock’s price action and financial disclosures closely as the company navigates this challenging phase.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →